Anja Wolf - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Anja Wolf

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Molecular Therapy. Methods & Clinical Development|January 5, 2024

Regnase-1 overexpression as a therapeutic approach of Marfan syndromeMarie Noormalal, Nesrin Schmiedel, Tarik Bozoglu, et al.

Cancer Research|November 19, 2010

An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivityJessika Wynendaele, Anja Böhnke, Eleonora Leucci, et al.

NPJ Precision Oncology|February 6, 2026

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancerKathrin B Labrosse, Flavio C Lombardo, Ewelina M Bartoszek, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Molecular Therapy. Methods & Clinical Development|January 5, 2024

Regnase-1 overexpression as a therapeutic approach of Marfan syndromeMarie Noormalal, Nesrin Schmiedel, Tarik Bozoglu, et al.

Cancer Research|November 19, 2010

An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivityJessika Wynendaele, Anja Böhnke, Eleonora Leucci, et al.

NPJ Precision Oncology|February 6, 2026

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancerKathrin B Labrosse, Flavio C Lombardo, Ewelina M Bartoszek, et al.

Pageof 3